← k3vl4r
Log inGet started →

NVS (Novartis) Price Forecast

AI-generated price forecast for Novartis (NVS) across 1-hour, 4-hour, daily and weekly horizons — updated continuously, with a public accuracy track record.

The desk streams live daily· see the schedule →

As of August 2026: K3vl4r's AI model currently reads NVS as 1/1 bearish across its horizons (0 of 1 timeframes pointing up), with a last price of 153.20. See our public, auditable track record →

📈 Daily Top Picks beating the S&P 500 since launch→✓ Public, verifiable track record Live system status💎 Get the full AI report · pay with XRP

Last price

153.20

AI outlook

1/1 bearish

Timeframes up

0 / 1

Share𝕏PostTelegram

NVS forecast by horizon

HorizonDirectionProjected move (end of horizon)Bullish prob.
1-hour———
4-hour~7 weeks out———
Daily~4 months out▼ Down-16.91%—
Weekly~1.9 years out———

Congressional trades in NVS

Public STOCK Act disclosures · amounts are ranges, reported up to ~45 days after the trade.

MemberActionDateAmount
Alan Armstrong▲ Buy2026-03-31$1001–15000
Alan Armstrong▲ Buy2026-03-30$15001–50000

Track what Congress is trading across the whole market in the app — get started free.

Latest NVS news

From the market-news feed the forecasts are read against.

  • Prediction market Novig sues Wisconsin AG in latest spat over sports contracts · ldr:coinstats.app · Aug 16
  • Update: Market Chatter: Novartis Wins UK Court Challenge to Entresto Patent · MT Newswires · Aug 13
  • Novartis India Approves Termination Of Distribution Agreement With Dr. Reddy’s Laboratories; Termination Agreement With Dr. Reddy’s Effective September 30, 2026; To Re-Buy Exclusivity And Market Access For Products After DRL Agreement Termination · Benzinga · Aug 7
  • Amgen: The Market Is Underestimating Its Next Growth Phase · SeekingAlpha · Aug 7
  • MHRA Approves Remibrutinib For Adults With Chronic Spontaneous Urticaria · Benzinga · Aug 6

🔒

See the full NVS forecast

Interactive forecast chart, price targets, and Monte-Carlo confidence bands — plus the daily AI Top Picks book. Free to start, no card required.

Create a free account →

Already have one? Log in

NVS forecast — frequently asked

Will NVS go up?

K3vl4r's AI model currently reads NVS as 1/1 bearish — 0 of 1 forecast horizons point up, so the overall read is leaning to the downside. This is a model-generated forecast for information only — not investment advice, and forecasts may be inaccurate.

What is the NVS price prediction for 2026?

K3vl4r's model projects NVS toward $152.10 over the next ~4 months, a -0.2% move from $152.36. Projections update continuously as new data arrives and are inherently uncertain. This is a model-generated forecast for information only — not investment advice, and forecasts may be inaccurate.

Part of Biotech & Pharma forecasts — browse the full sector.

More AI forecasts

PCRXBMYNVOAZNPFESNYPRGOLLYGSKJNJABBVMRKRPRXTEVA

Will NVS reach…?

Will NVS reach $200.00?Will NVS reach $250.00?Will NVS reach $500.00?Will NVS reach $1,000?

Or see the full NVS price prediction (2027–2040), or the forecast for today, tomorrow and this week.

Compare NVS

NVS vs PCRXNVS vs BMYNVS vs NVONVS vs AZNNVS vs PFENVS vs SNY

Curious how this is generated? Read how K3vl4r forecasts — the model, the confidence bands, and what we deliberately do not claim.

K3vl4r publishes a public, auditable track record of its Daily Top Picks — see the live results.

Forecasts are model-generated estimates for informational purposes only and are not financial advice. Markets are risky; past accuracy does not guarantee future results. See our Risk Disclosure.

StreamWatch on Kick·Watch on YouTube
k3vl4rTop PicksTrack recordChart indicatorsToday's outlookStream scheduleBiggest moversMarket heatmapForecasts by sectorAI reportsMarket videosCompareMethodologyBest AI toolsAboutFAQ◈ KVLHow KVL worksTokenomicsPricingX (Twitter)YouTube — daily showsTikTokTwitch — live forecastingDiscord community

Join the community on Discord and catch the desk stream live on Kick or YouTube. Create a free account →

Forecasts are AI-generated; written analysis is AI-assisted and human-reviewed. Informational only, not financial advice. See Terms, Risk Disclosure, Privacy · Methodology · Status.